Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioCryst Pharmaceuticals Inc

+ Add to Watchlist

BCRX:US

11.2200 USD 0.1000 0.88%

As of 14:38:28 ET on 05/28/2015.

Company Profile for BioCryst Pharmaceuticals Inc (BCRX)

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases & cancer. The Company has late-stage compounds in development & continues to discover additional compounds & to progress them to meet the unmet medical needs of patients and physicians.

Contact Information

BioCryst Pharmaceuticals Inc

4505 Emperor Blvd
Suite 200
Durham, NC 27703
United States
Phone: 1-919-859-1302
Fax: 1-205-444-4640

Key Executives for BioCryst Pharmaceuticals Inc (BCRX)

Jon P StonehousePresident/CEOThomas R Staab II "Tom"Senior VP/CFO/Chief Acctg Ofcr
Lynne PowellSenior VP/Chief Commercial OfcrWilliam P SheridanSenior VP/Chief Medical Ofcr
Yarlagadda S BabuSenior VP:Drug DiscoveryAlane P BarnesVP/Secretary/General Counsel
Robert Bennett "Rob"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil